Forte Biosciences, Inc. (FBRX)
32.11
+1.33
(+4.32%)
USD |
NASDAQ |
Feb 13, 16:00
31.44
-0.67
(-2.09%)
After-Hours: 20:00
Forte Biosciences EPS Diluted (Quarterly) : -0.9937 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Agenus, Inc. | 1.944 |
| Alnylam Pharmaceuticals, Inc. | 1.840 |
| Savara, Inc. | -0.1366 |
| Arrowhead Pharmaceuticals, Inc. | 0.219 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -17.68M |
| Total Expenses (Quarterly) | 17.68M |
| Enterprise Value | 308.82M |
| Earnings Yield | -13.84% |
| Normalized Earnings Yield | -13.84 |